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Background

Results

§ Abuse of opioids has shifted from oral to injection use,
resulting in greater risk of infectious disease transmission
§ The number of new Hepatitis C virus (HCV) infections in
the US has tripled
§ Treating acute infections of HCV vs. managing chronic
Hepatitis C is expected to result in $12 billion in total
cumulative savings to Medicaid by 2022
§ Despite engagement in treatment, individuals with opioid
use disorder (OUD) remain at risk for contracting and
transmitting infectious disease, yet many mOUD programs
screen patients upon admission only.

Discussion
§

§
§

§

A brief questionnaire administered to patients regarding
risk factors for HCV can help facilitate targeted
screening efforts
Uptake of re-screening may improve if less invasive
screening modalities were used
Nursing staff agreed that re-screening surveys were
easy to implement, and introduced opportunities to talk
with patients about their risk factors for contracting
HCV, and review the importance of routine screening
Stakeholders agreed that routine surveillance of HCV is
important, and fits within the the scope of practice of
mOUD treatment

Purpose
§
§

Implement a HCV re-screening protocol in a mOUD
program and determine sustainability of protocol
Secondarily, determine if point of care finger stick tests
would be a preferred modality to use for screening

Implications for Future Practice
§ Risk questionnaires could be distributed to patients
receiving medication for OUD in primary care settings
§ Surveillance services offered in mOUD treatment
programs may qualify for enhanced-rate reimbursement
§ In addition to on-site identification of HCV, treatment of
HCV in a mOUD setting is cost effective and patient
centered

Methods
§

§
§

§
§

Patients with an unknown or negative HCV antibody
test result upon admission were offered to complete a
risk survey
§
Patients were given a list of risk factors for
HCV, and asked to answer if they applied
YES/NO
§
IF YES, patients were asked if they would
like be re-screened for HCV
If interested in rescreening, patients were offered an
onsite venipuncture
Patients who declined rescreening, were asked if they
would re-consider if the testing modality was a finger
stick
Patients with a positive HCV RNA viral load received a
referral to UVMMC Infectious Disease
Nursing staff, medical providers, and administrative
leaders provided feedback via an online survey

Conclusion
§

Survey Questions
1. The risk survey was easy to administer to patients.
2. Administering the risk survey at the dosing window did not interrupt
work flow.
3. Administering the risk survey at the dosing window did not interfere
with responsibilities of the dosing nurse.
4. Entering and updating flags in the electronic health system to facilitate
surveillance of HCV is feasible to add to nursing work flow.
5. I am comfortable performing venipuncture on patients who wish to be
re-screened at the clinic.
6. I would be comfortable performing a finger stick at the dosing window
to collect a sample of blood to re-screen patients for HCV if proper
training were provided.
7. Having patients complete the risk survey at the window presents a brief
opportunity to educate patients about the risk factors for Hepatitis C
and the importance of routine screening.
8. Dispensing HCV medication with a patient’s daily dose is easy and is
an effective strategy to promote medication adherence.

Survey Questions
1. It is important to re-screen patients who had a negative HCV antibody result
upon admission to the Chittenden Clinic.
2. It is important to offer re-screening for HCV antibody to patients at the
Chittenden Clinic 6 months after the initial negative result.
3. It is important to offer re-screening for HCV antibody to patients at the
Chittenden Clinic 1 year after the initial negative result.
4. It is within the Chittenden Clinic’s scope of practice and treatment program
to offer health care services such as screening, diagnosing, and care
coordination for patients at risk for and/or who have an infectious disease.
5. Re-screening for infectious disease, is the responsibility of the patient’s
primary care provider or public health service team, and not the
responsibility of the Chittenden Clinic.
6. Point of care testing for HCV is a service that should be offered to patients at
the Chittenden Clinic.
7. It is important for Chittenden Clinic providers to be able to prescribe
medications to treat Hepatitis C.
8. The Chittenden Clinic offers a unique environment in which the
identification and treatment of Hepatitis C can be can managed effectively.
9. It is the role and responsibility of the Chittenden Clinic care team to educate
patients on the risk of contracting Hepatitis C.
10. The Chittenden Clinic should prioritize improving the surveillance of
infectious disease among its patients.

Integration of HCV surveillance services at mOUD
treatment programs provides a sustainable approach to
reduce the public health burden of infectious disease

